CBD Life Sciences (CBDL) Stock Price, News & Analysis

Company Overview

CBD Life Sciences, Inc. (OTCMKTS:CBDL) is a U.S.-based company associated with the development and marketing of cannabidiol (CBD) and other hemp-derived wellness products.

Its product activities have included CBD-focused consumer goods, such as dietary supplements and personal-care or topical products. The company has promoted these products for general wellness purposes and has operated primarily through online and direct-to-consumer sales channels.

Publicly available information about CBD Life Sciences’ current operations, geographic reach, product portfolio, and leadership is limited. Accordingly, details about its present business activities and management cannot be reliably confirmed.

Key Stats

• Today's Range: $0.0001 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0010
• Volume: 10.37 million shs
• Average Volume: 13.06 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CBDL
• CIK: 1776073
• Web: lbcbioscienceinc.com
• Phone: (480) 410-6780
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A